Phase I results of mitoxantrone in combination with clofarabine in children with refractory/relapsed acute leukemia

被引：0
|
作者：
Hochberg, Jessica
Oesterheld, Javier
Militano, Olga
Klejmont, Liana
Harrison, Lauren
Nickerson, Berkley
Cairo, Mitchell S.
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-3203
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3203
引用
下载
收藏
页数：4
相关论文
共 50 条
  • [21] MITOXANTRONE FOR REFRACTORY AND RELAPSED ACUTE-LEUKEMIA
    BEZWODA, WR
    BERNASCONI, C
    HUTCHINSON, RM
    WINFIELD, DA
    DEBOCK, R
    MANDELLI, F
    CANCER, 1990, 66 (03) : 418 - 422
  • [22] MITOXANTRONE IN RELAPSED OR REFRACTORY ACUTE NONLYMPHOCYTIC LEUKEMIA
    VREDENBURGH, JJ
    MCINTYRE, OR
    CORNWELL, GG
    BALI, ED
    CORNELL, CJ
    MILLS, LE
    ODONNELL, JF
    MEDICAL AND PEDIATRIC ONCOLOGY, 1988, 16 (03): : 187 - 189
  • [23] MITOXANTRONE IN RELAPSED OR REFRACTORY ACUTE MYELOGENOUS LEUKEMIA
    VREDENBURG, JJ
    MCINTYRE, OR
    CORNWELL, GG
    BALL, ED
    CORNELL, CJ
    LEUKEMIA, 1987, 1 (03) : 278 - 278
  • [24] MITOXANTRONE IN RELAPSED AND REFRACTORY ACUTE-LEUKEMIA
    PRENTICE, HG
    ROBBINS, G
    MA, DDF
    HO, AD
    SEMINARS IN ONCOLOGY, 1984, 11 (03) : 32 - 35
  • [25] MITOXANTRONE IN REFRACTORY ACUTE-LEUKEMIA IN CHILDREN - A PHASE-I STUDY
    STARLING, KA
    MULNE, AF
    VATS, TS
    SCHOCH, I
    DUKART, G
    INVESTIGATIONAL NEW DRUGS, 1985, 3 (02) : 191 - 195
  • [26] Phase I evaluation of prolonged-infusion gemcitabine with mitoxantrone for relapsed or refractory acute leukemia
    Rizzieri, DA
    Bass, AJ
    Rosner, GL
    Gockerman, JP
    DeCastro, C
    Petros, WP
    Adams, DJ
    Laughlin, MJ
    Davis, P
    Foster, T
    Jacobson, R
    Hurwitz, H
    Moore, JO
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (03) : 674 - 679
  • [27] Phase I and Extension Study of Clofarabine Plus Cyclophosphamide in Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
    Faderl, Stefan
    Balakrishnan, Kumudha
    Thomas, Deborah A.
    Ravandi, Farhad
    Borthakur, Gautam
    Burger, Jan
    Ferrajoli, Alessandra
    Cortes, Jorge
    O'Brien, Susan
    Kadia, Tapan
    Feliu, Jennie
    Plunkett, William
    Gandhi, Varsha
    Kantarjian, Hagop M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 (03): : 231 - 238
  • [28] Combination of clofarabine, cyclophosphamide, and etoposide for relapsed or refractory childhood and adolescent acute myeloid leukemia
    Messinger, Yoav
    Boklan, Jessica
    Goldberg, John
    DuBois, Steven G.
    Oesterheld, Javier
    Abla, Oussama
    Martin, Alissa
    Weinstein, Joanna
    Hijiya, Nobuko
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2017, 34 (04) : 187 - 198
  • [29] A phase I dose-escalation study of clofarabine in combination with fractionated gemtuzumab ozogamicin in patients with refractory or relapsed acute myeloid leukemia
    Foster, Matthew C.
    Amin, Chirag
    Voorhees, Peter M.
    Van Deventer, Hendrik W.
    Richards, Kristy L.
    Ivanova, Anastasia
    Whitman, Jennifer
    Chiu, Wingkeung Michael
    Barr, Nathan D.
    Shea, Thomas
    LEUKEMIA & LYMPHOMA, 2012, 53 (07) : 1331 - 1337
  • [30] Durable Remissions Observed in a Phase I/II Study of Clofarabine in Combination with Etoposide and Cyclophosphamide in Pediatric Patients with Refractory or Relapsed Acute Leukemia
    Huiya, Nobuko
    Gaynon, Paul S.
    Femandez, Manuel
    Silverman, Lewis B.
    Thomson, Blythe
    Chu, Roland
    Cooper, Todd
    Kadota, Richard
    Rytting, Michael
    Steinherz, Peter G.
    Shen, Violet
    Jeha, Sima
    Barry, Elly
    Carroll, William L.
    BLOOD, 2008, 112 (11) : 1006 - 1006
12345